Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 160851-160900 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT02065557
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
PHASE3
Completed
101 participants
Started: Oct 13, 2014 · Completed: Feb 7, 2020
1 condition
1 sponsor
60 locations
NCT02279732
Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and Carboplatin
PHASE3
Completed
342 participants
Started: Oct 13, 2014 · Completed: May 3, 2018
1 condition
1 sponsor
49 locations
NCT02269280
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)
PHASE2
Completed
185 participants
Started: Oct 13, 2014 · Completed: Jul 25, 2024
1 condition
2 sponsors
6 locations
NCT02172950
An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A
PHASE3
Completed
246 participants
Started: Oct 13, 2014 · Completed: Jan 19, 2021
2 conditions
1 sponsor
64 locations
NCT02269423
Vaccine Treatment for Ebola Virus in Healthy Adults (V920-001)
PHASE1
Completed
39 participants
Started: Oct 13, 2014 · Completed: Aug 25, 2015
1 condition
3 sponsors
0 locations
NCT02269293
Selective Inhibitor of Nuclear Export, Selinexor (KPT-330) in Combination With Paclitaxel and Carboplatin in Patients With Advanced Ovarian or Endometrial Cancers
PHASE1
Completed
23 participants
Started: Oct 13, 2014 · Completed: Apr 20, 2021
2 conditions
1 sponsor
3 locations
NCT06333054
Safety and Efficacy of a Head Lice Shampoo
NA
Completed
109 participants
Started: Oct 13, 2014 · Completed: Jun 8, 2015
1 condition
1 sponsor
1 location
NCT03230396
Vitamin Gum Pharmacokinetics
NA
Completed
15 participants
Started: Oct 13, 2014 · Completed: Jul 1, 2015
1 condition
2 sponsors
0 locations
NCT02202291
Prospective Multicenter Study on the Identification of Genetic Abnormalities Predisposing to Vasospasm From a Privileged Model: the Primary Raynaud's Phenomenon
NA
Completed
258 participants
Started: Oct 13, 2014 · Completed: Jun 10, 2020
3 conditions
1 sponsor
6 locations
NCT06068712
Proactive and Reactive Attention to Negative Templates
NA
Completed
19 participants
Started: Oct 11, 2014 · Completed: Apr 2, 2015
1 condition
1 sponsor
1 location
NCT03406065
Sodium Bicarbonate Supplementation in Combat Sports Athletes
PHASE2/PHASE3
Completed
64 participants
Started: Oct 10, 2014 · Completed: Apr 5, 2015
2 conditions
2 sponsors
1 location
NCT02296320
Study of the Efficacy and Safety of MEDI4893
PHASE2
Completed
213 participants
Started: Oct 10, 2014 · Completed: Oct 2, 2018
1 condition
4 sponsors
49 locations
NCT02166905
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
PHASE1/PHASE2
Completed
40 participants
Started: Oct 10, 2014 · Completed: Aug 20, 2020
3 conditions
4 sponsors
1 location
NCT03148249
A Trial of Patients With a Charles Bonnet Syndrome
NA
Completed
34 participants
Started: Oct 10, 2014 · Completed: Feb 1, 2017
1 condition
1 sponsor
0 locations
NCT02130869
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
PHASE1
Completed
8 participants
Started: Oct 10, 2014 · Completed: Dec 20, 2017
3 conditions
1 sponsor
1 location
NCT02262819
Human Immunity Against Staphylococcus Aureus Skin Infection
PHASE1
Completed
49 participants
Started: Oct 10, 2014 · Completed: Apr 24, 2019
1 condition
1 sponsor
1 location
NCT00862433
Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women
PHASE1
Completed
50 participants
Started: Oct 10, 2014 · Completed: May 3, 2022
4 conditions
1 sponsor
1 location
NCT02284009
Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes Mellitus
PHASE2
Completed
67 participants
Started: Oct 10, 2014 · Completed: Oct 18, 2017
1 condition
1 sponsor
32 locations
NCT02090101
Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer
PHASE2
Completed
32 participants
Started: Oct 10, 2014 · Completed: May 15, 2017
1 condition
1 sponsor
1 location
NCT02268695
Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC
PHASE2
Completed
541 participants
Started: Oct 10, 2014 · Completed: Dec 31, 2021
1 condition
3 sponsors
17 locations
NCT02268383
Extension Study to Evaluate Long-Term Effects of Luspatercept in Patients With Myelodysplastic Syndromes (MDS) (A536-05/MK-6143-003)
PHASE2
Completed
75 participants
Started: Oct 9, 2014 · Completed: Mar 19, 2020
1 condition
1 sponsor
1 location
NCT02269241
Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles
PHASE3
Completed
1,552 participants
Started: Oct 9, 2014 · Completed: Oct 4, 2017
1 condition
2 sponsors
37 locations
NCT02123797
Building a Multidisciplinary Bridge Across the Quality Chasm in Thoracic Oncology
N/A
Completed
781 participants
Started: Oct 9, 2014 · Completed: Feb 29, 2020
1 condition
2 sponsors
1 location
NCT02057081
Multifamily Group to Reduce Marital Conflict and Disability in Veterans With mTBI
NA
Completed
249 participants
Started: Oct 9, 2014 · Completed: Aug 31, 2019
3 conditions
1 sponsor
3 locations
NCT02279095
An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
PHASE2
Completed
58 participants
Started: Oct 9, 2014 · Completed: Sep 20, 2022
1 condition
1 sponsor
8 locations
NCT02193880
Safety of Post-transplant Alpha-beta Depleted T-cell Infusion Following Haploidentical Stem Cell Transplant (Haplo SCT)
NA
Completed
7 participants
Started: Oct 9, 2014 · Completed: Mar 13, 2018
2 conditions
1 sponsor
1 location
NCT02070458
Ixazomib, Mitoxantrone Hydrochloride, Etoposide, and Intermediate-Dose Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia
PHASE1
Completed
30 participants
Started: Oct 8, 2014 · Completed: Aug 15, 2017
2 conditions
2 sponsors
2 locations
NCT02291874
Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
PHASE4
Completed
100 participants
Started: Oct 8, 2014 · Completed: Jul 7, 2016
1 condition
1 sponsor
6 locations
NCT04414644
Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism
NA
Completed
17 participants
Started: Oct 8, 2014 · Completed: Jun 5, 2017
1 condition
4 sponsors
1 location
NCT02015559
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus
PHASE2
Completed
61 participants
Started: Oct 8, 2014 · Completed: Nov 30, 2018
8 conditions
2 sponsors
1 location
NCT02278055
Non-Randomized Trial Assessing Pain Efficacy With Radium-223 in Symptomatic Metastatic Castration-Resistant Prostate Cancer
PHASE2
Completed
29 participants
Started: Oct 8, 2014 · Completed: Feb 2, 2022
2 conditions
3 sponsors
3 locations
NCT02258438
Effect of Breaking up Prolonged Sitting on Metabolic Flexibility
NA
Completed
28 participants
Started: Oct 8, 2014 · Completed: Sep 30, 2017
1 condition
1 sponsor
1 location
NCT02072174
Efficacy of Anaferon for Children in the Treatment of Influenza and Acute Respiratory Viral Infections in Children
PHASE4
Completed
569 participants
Started: Oct 8, 2014 · Completed: Apr 16, 2018
1 condition
1 sponsor
27 locations
NCT01956669
Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors
PHASE2
Completed
57 participants
Started: Oct 8, 2014 · Completed: Nov 5, 2019
1 condition
2 sponsors
31 locations
NCT02346968
Evaluation of CAF22 After Renal Transplantation
N/A
Completed
99 participants
Started: Oct 8, 2014 · Completed: Sep 27, 2018
2 conditions
1 sponsor
2 locations
NCT02248259
Drug Drug Interaction Trial With Strong CYP3A4 Inhibitor (Itraconazole) in CYP2C19 Extensive Metabolizers and Poor Metabolizers
PHASE1
Completed
25 participants
Started: Oct 8, 2014 · Completed: Jan 8, 2015
1 condition
1 sponsor
1 location
NCT02253420
COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients
PHASE1
Completed
51 participants
Started: Oct 8, 2014 · Completed: Aug 13, 2019
1 condition
1 sponsor
5 locations
NCT01876745
A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan
N/A
Completed
4 participants
Started: Oct 7, 2014 · Completed: Jun 1, 2017
2 conditions
1 sponsor
1 location
NCT02015819
Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas
PHASE1
Completed
16 participants
Started: Oct 7, 2014 · Completed: Oct 7, 2017
7 conditions
2 sponsors
1 location
NCT02230553
Lapatinib Plus Trametinib in KRAS Mutant NSCLC
PHASE1/PHASE2
Completed
35 participants
Started: Oct 7, 2014 · Completed: Aug 6, 2019
1 condition
2 sponsors
1 location
NCT01930162
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant
PHASE2
Completed
9 participants
Started: Oct 7, 2014 · Completed: Aug 29, 2016
7 conditions
1 sponsor
1 location
NCT02984748
Outcome Prediction in Cochlear Implant Recipients
N/A
Completed
267 participants
Started: Oct 7, 2014 · Completed: Dec 31, 2020
1 condition
4 sponsors
1 location
NCT02156804
A Single-Arm, Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) for Subjects With Histologically Confirmed Stage III (Unresectable) or Stage IV Melanoma Progressing Post Prior Treatment Containing an Anti-CTLA4 Monoclonal Antibody (CheckMate 172)
PHASE2
Completed
1,009 participants
Started: Oct 7, 2014 · Completed: Jan 18, 2019
1 condition
1 sponsor
170 locations
NCT02212262
Role of Osteocytes in Myeloma Bone Disease
N/A
Completed
67 participants
Started: Oct 7, 2014 · Completed: Feb 5, 2022
1 condition
1 sponsor
2 locations
NCT02203032
A Study of Guselkumab in Participants With Moderate to Severe Plaque-type Psoriasis and an Inadequate Response to Ustekinumab
PHASE3
Completed
872 participants
Started: Oct 7, 2014 · Completed: May 24, 2016
1 condition
1 sponsor
85 locations
NCT02113033
VAgal Nerve Stimulation: safeGUARDing Heart Failure Patients
PHASE2
Completed
15 participants
Started: Oct 7, 2014 · Completed: Sep 20, 2016
1 condition
1 sponsor
6 locations
NCT03077334
Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer
N/A
Completed
200 participants
Started: Oct 7, 2014 · Completed: Sep 17, 2018
1 condition
1 sponsor
1 location
NCT02280408
Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)
PHASE1
Completed
39 participants
Started: Oct 7, 2014 · Completed: Dec 10, 2015
1 condition
3 sponsors
0 locations
NCT02553954
Molecular Mechanisms of Senescence Predisposing to Cancer : Exploratory Analysis on Healthy Tissues (SkinAge).
NA
Completed
58 participants
Started: Oct 7, 2014 · Completed: Apr 30, 2020
1 condition
2 sponsors
1 location
NCT02216214
Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)
PHASE4
Completed
888 participants
Started: Oct 7, 2014 · Completed: Jan 2, 2018
1 condition
1 sponsor
120 locations
Previous
1
More pages
3215
3216
3217
3218
3219
3220
3221
More pages
6093
Next